Pascal
Payments companies reported to CMS as associated with Pascal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pascal, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pascal
These are the largest totals companies reported as associated with Pascal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jyothy Puthumana | Chicago, IL | Cardiovascular Disease | $118,688.06 |
| Brian Stegman | St Cloud, MN | Interventional Cardiology | $106,036.76 |
| Thomas Waggoner | Tucson, AZ | Interventional Cardiology | $101,140.22 |
| Stephen Kidd | Saint Cloud, MN | Interventional Cardiology | $96,887.53 |
| Kamran Muhammad | Tulsa, OK | Interventional Cardiology | $84,310.06 |
| Thom Dahle | Saint Cloud, MN | Interventional Cardiology | $80,060.25 |
| Firas Zahr | Portland, OR | Cardiovascular Disease | $79,128.63 |
| Kevin Evans | Tucson, AZ | Anesthesiology | $63,209.99 |
| Antonio Halais Frangieh | Orange, CA | Interventional Cardiology | $62,602.94 |
| Rahul Sharma | Stanford, CA | Interventional Cardiology | $59,764.57 |
Prescribed Pascal?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.